BACKGROUND & AIMS: Germline mutations in the APC gene cause of most cases of familial adenomatous polyposis (FAP) and a lesser proportion of attenuated FAP (AFAP). Systematic analysis of APC at the RNA level could provide insight into the pathogenicity of identified mutations and the molecular basis of FAP/AFAP in families without identifiable mutations. Here, we analyzed the prevalence of imbalances in the allelic expression of APC in polyposis families with germline mutations in the gene and without detectable mutations in APC and/or MUTYH. METHODS: Allele-specific expression (ASE) was determined by single nucleotide primer extension using an exon 11 polymorphism as an allele-specific marker. In total, 52 APC-mutation-positive (36 families) and 24 APC/MUTYH-mutation-negative (23 families) informative patients were analyzed. Seventy-six controls also were included. RESULTS: Of the APC-mutation-positive families, most of those in whom the mutation was located before the last exon of the gene (12 of 14) had ASE imbalance, which is consistent with a mechanism of nonsense-mediated decay. Of the APC/MUTYH-mutation-negative families, 2 (9%) had ASE imbalance, which might cause the disease. Normal allele expression was restored shortly after lymphocytes were cultured with puromycin, supporting a 'nonsense-mediated' hypothesis. CONCLUSIONS: ASE analysis might be used to determine the pathogenesis of some cases of FAP and AFAP in which APC mutations are not found. ASE also might be used to prioritize the order in which different areas of APC are tested. RNA-level studies are important for the molecular diagnosis of FAP. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
BACKGROUND & AIMS: Germline mutations in the APC gene cause of most cases of familial adenomatous polyposis (FAP) and a lesser proportion of attenuated FAP (AFAP). Systematic analysis of APC at the RNA level could provide insight into the pathogenicity of identified mutations and the molecular basis of FAP/AFAP in families without identifiable mutations. Here, we analyzed the prevalence of imbalances in the allelic expression of APC inpolyposis families with germline mutations in the gene and without detectable mutations in APC and/or MUTYH. METHODS: Allele-specific expression (ASE) was determined by single nucleotide primer extension using an exon 11 polymorphism as an allele-specific marker. In total, 52 APC-mutation-positive (36 families) and 24 APC/MUTYH-mutation-negative (23 families) informative patients were analyzed. Seventy-six controls also were included. RESULTS: Of the APC-mutation-positive families, most of those in whom the mutation was located before the last exon of the gene (12 of 14) had ASE imbalance, which is consistent with a mechanism of nonsense-mediated decay. Of the APC/MUTYH-mutation-negative families, 2 (9%) had ASE imbalance, which might cause the disease. Normal allele expression was restored shortly after lymphocytes were cultured with puromycin, supporting a 'nonsense-mediated' hypothesis. CONCLUSIONS:ASE analysis might be used to determine the pathogenesis of some cases of FAP and AFAP in which APC mutations are not found. ASE also might be used to prioritize the order in which different areas of APC are tested. RNA-level studies are important for the molecular diagnosis of FAP. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Authors: Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle Journal: Nat Genet Date: 2002-01-30 Impact factor: 38.330
Authors: J Groden; A Thliveris; W Samowitz; M Carlson; L Gelbert; H Albertsen; G Joslyn; J Stevens; L Spirio; M Robertson Journal: Cell Date: 1991-08-09 Impact factor: 41.582
Authors: Daniel Herzig; Karin Hardiman; Martin Weiser; Nancy You; Ian Paquette; Daniel L Feingold; Scott R Steele Journal: Dis Colon Rectum Date: 2017-09 Impact factor: 4.585
Authors: Maria Cristina Curia; Sabrina De Iure; Laura De Lellis; Serena Veschi; Sandra Mammarella; Marquitta J White; Jacquelaine Bartlett; Angelo Di Iorio; Cristina Amatetti; Marco Lombardo; Patrizia Di Gregorio; Pasquale Battista; Renato Mariani-Costantini; Scott M Williams; Alessandro Cama Journal: Gastroenterology Date: 2011-10-10 Impact factor: 22.682
Authors: A Rohlin; Y Engwall; K Fritzell; K Göransson; A Bergsten; Z Einbeigi; M Nilbert; P Karlsson; J Björk; M Nordling Journal: Oncogene Date: 2011-06-06 Impact factor: 9.867
Authors: Ana Martinez-Canto; Adela Castillejo; Trinidad Mata-Balaguer; Maria-Isabel Castillejo; Eva Hernandez-Illan; Esperanza Irles; Victor Manuel Barbera; Cecilia Egoavil; Carla Guarinos; Cristina Alenda; Enrique Ochoa; Rafael Lazaro; Silvia Fajardo; Javier Lacueva; Rafael Calpena; Jose Luis Soto Journal: PLoS One Date: 2012-01-23 Impact factor: 3.240
Authors: Laura De Lellis; Gitana Maria Aceto; Maria Cristina Curia; Teresa Catalano; Sandra Mammarella; Serena Veschi; Fabiana Fantini; Pasquale Battista; Vittoria Stigliano; Luca Messerini; Cristina Mareni; Paola Sala; Lucio Bertario; Paolo Radice; Alessandro Cama Journal: PLoS One Date: 2013-11-20 Impact factor: 3.240